Источники:
Peptide Therapeutics Market Size & Growth Report 2033imarcgroup.com/peptide-therap…Peptide Therapeutics Market Size & Growth Report 2033The global peptide therapeutics market size was valued at USD 46.17 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 91.87 Billion by 2033, exhibiting a CAGR of 7.55% during 2025-2033.
GrandViewIncgrandviewresearch.com/industry-analy…Peptide Therapeutics Market Size | Industry Report, 2030The global peptide therapeutics market size was estimated at USD 117.26 billion in 2024 and is projected to reach USD 260.25 billion by 2030, growing at a CAGR of 10.77% from 2025 to 2030.
Research and Marketsglobenewswire.com/news-release/2…Peptide Therapeutics Market Outlook 2025-2030 - NorthDublin, March 18, 2025 (GLOBE NEWSWIRE) -- The
Transparency Market Researchtransparencymarketresearch.com/peptide-therap…Peptide Therapeutics Market - Growth and Forecast to 2035The Peptide Therapeutics Market is projected to grow at a CAGR of 9.5% from 2025 to 2035, reaching over US$ 123.2 billion by 2035. Increasing applications in chronic disease treatments and advancements in peptide-based drug development are driving market growth.
Research And Marketsresearchandmarkets.com/reports/576734…Peptide Therapeutics Market Report 2025The Peptide Therapeutics Market, valued at USD 49.21B in 2025, is projected to reach USD 74.98B by 2029, growing at a 11.1% CAGR.
GrandViewIncgrandviewresearch.com/horizon/outloo…US Peptide Therapeutics Market Size & Outlook, 2023-2030The peptide therapeutics market in the United States is expected to reach a projected revenue of US$ 160,325.0 million by 2030. A compound annual growth rate of 16.2% is expected of the United States peptide therapeutics market from 2024 to 2030.
Research Nesterresearchnester.com/reports/peptid…Peptide Therapeutics Market Size and Forecast, by ...The global peptide therapeutics market size was over USD 47.65 billion in 2024 and is anticipated to witness more than 9.8% CAGR between 2025 and 2034, fueled by a well-established biopharmaceutical industry.
Cognitive Market Researchcognitivemarketresearch.com/regional-analy…Asia Pacific Peptide Therapeutics Drugs Market Report 2025Asia Pacific peptide therapeutics drugs market will be USD 8864.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031. Significant investment in R&D by pharmaceutical companies is expected to aid sales to USD 21139.2 million by 2031
Nova One Advisornovaoneadvisor.com/report/glp-1-t…GLP-1 Targeted Peptide Weight Loss Drugs Market Size ...The GLP-1 Targeted Peptide Weight Loss Drugs market size was estimated at USD 61.18 billion in 2024 and is expected to reach USD 193.44 billion by 2034, growing at a CAGR of 12.2% from 2025 to 2034.
Fbinsightpvtltdfortunebusinessinsights.com/glp-1-receptor…GLP-1 Receptor Agonist Market Size, Share | Growth [2032]The global GLP-1 receptor agonist market size was valued at $52.08 billion in 2024 & is projected to grow from $62.83 billion in 2025 to $186.64 billion by 2032
iHealthcareAnalyst, Inc. - Healthcare Market Researchihealthcareanalyst.com/global-glp-1-r…Global GLP-1 Receptor Agonists Market $147 Billion by 2033The global market for GLP-1 receptor agonists predicted to reach $147 billion by 2033, expanding at a double digit CAGR of 11.1% over the forecast period,
Towards Healthcaretowardshealthcare.com/insights/glp1-…GLP-1 Drugs Market Size to Lead USD 121.13 Bn by 2034The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 121.13 billion by 2034, driven by a CAGR of 9.63%.
Investing.cominvesting.com/analysis/eli-l…Eli Lilly Vs. Novo Nordisk: Which Pharma Stock Is Likely to ...Market Analysis by covering: Eli Lilly and Company, Novo Nordisk A/S. Read 's Market Analysis on Investing.com
Future Market Insightsfuturemarketinsights.com/reports/peptid…Peptide Synthesis Market Outlook 2025 to 2035Discover how advancements in automated peptide synthesis are enhancing drug discovery, proteomics, and personalized medicine.
CordenPharmacordenpharma.com/resources/cord…Tag-Assisted Peptide Synthesis (TAPS): Continuous Liquid ...CordenPharma presents Tag-Assisted Peptide Synthesis (TAPS) for development sustainable & cost-effective Continuous Liquid-Phase manufacturing.
Data Bridge Market Research, https://www.databridgemarketresearch.com, All right reserved 2025databridgemarketresearch.com/reports/global…Global Peptide Synthesis Market – Industry Trends and ...The Peptide Synthesis market was valued at USD 4.70 Billion in 2022 and is expected to reach USD 8.82 Billion by 2030, growing at a CAGR of 8.2% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.
polifaces.depolifaces.de/2025/02/17/adv…Advancing Peptide-Based Drug Discovery with Artificial ...We are excited to highlight a recent publication featured in *Briefings in Bioinformatics*, titled “Peptide-Based Drug Discovery through Artificial Intelligence: Towards an Autonomous Design of Therapeutic Peptides”. This study, led by researchers from Universidad de Chile and Universidad de Magallanes, explores how artificial intelligence (AI) is revolutionizing the design and discovery of therapeutic peptides. Key Insights from the Study Peptides hold vast potential as therapeutic agents due...
Gubragubra.dk/blog/ai-in-dru…AI in drug discovery: Key trends shaping therapeutics in 2025Learn about AI in drug discovery. From de novo peptide design to ML-guided optimization. Explore Gubra's AI drug discovery techniques.
bioduro.combioduro.com/news-resources…BioDuro and Atombeat Announce Partnership to Launch ...IRVINE, Calif. – July 30, 2025 – BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), and Atombeat Inc., a leading force in AI for drug discovery, today
Mordor Intelligencemordorintelligence.com/industry-repor…Peptide Therapeutics Market Size & Share AnalysisThe peptide therapeutics market is forecast to grow at 7.06% CAGR and reach USD 65.20 billion by 2030, driven by rising R&D investments in novel drugs as well as increasing prevalence of cancer and metabolic disorders.
markets.financialcontent.commarkets.financialcontent.com/stocks/article…GLP-1 Titans Clash: Eli Lilly Challenges Novo Nordisk's ...GLP-1 Titans Clash: Eli Lilly Challenges Novo Nordisk's Dominance in a Spiraling Market Battle
Future Market Insightsfuturemarketinsights.com/reports/peptid…Peptide Drug Conjugates MarketPeptide Drug Conjugates Market was worth USD 1,240.0 million in 2025, and is predicted to grow to USD 7,677.8 million by 2035, with a CAGR of 20.0%.
Coherent Market Insightscoherentmarketinsights.com/market-insight…Peptide Therapeutics Market Size, YoY Growth Rate, 2025- ...Peptide Therapeutics Market size is growing with a CAGR of 6.6% in the prediction period and it crosses USD 78,898.8 Mn in 2032,from USD 50,439.4 Mn in 2025.
Naturenature.com/articles/s4139…Advance in peptide-based drug development: delivery ...The successful approval of peptide-based drugs can be attributed to a collaborative effort across multiple disciplines. The integration of novel drug design and synthesis techniques, display library technology, delivery systems, bioengineering advancements, and artificial intelligence have significantly expedited the development of groundbreaking peptide-based drugs, effectively addressing the obstacles associated with their character, such as the rapid clearance and degradation, necessitating subcutaneous injection leading to increasing patient discomfort, and ultimately advancing translational research efforts. Peptides are presently employed in the management and diagnosis of a diverse array of medical conditions, such as diabetes mellitus, weight loss, oncology, and rare diseases, and are additionally garnering interest in facilitating targeted drug delivery platforms and the advancement of peptide-based vaccines. This paper provides an overview of the present market and clinical trial progress of peptide-based therapeutics, delivery platforms, and vaccines. It examines the key areas of research in peptide-based drug development through a literature analysis and emphasizes the structural modification principles of peptide-based drugs, as well as the recent advancements in screening, design, and delivery technologies. The accelerated advancement in the development of novel peptide-based therapeutics, including peptide-drug complexes, new peptide-based vaccines, and innovative peptide-based diagnostic reagents, has the potential to promote the era of precise customization of disease therapeutic schedule.
Yahoofinance.yahoo.com/news/novo-nord…Novo Nordisk's diabetes and weight loss drug sales growth ...H1 sales growth for Novo's segment that includes Ozempic and Wegovy was down from the same period in 2024.
Polypeptide Grouppolypeptide.com/news/large-sca…Large-scale SPPS capacity in Braine-l'Alleud starts ...Baar, 16 December 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide-based active pharmaceutical ingredients, announces the start of production with the […]
Yahoofinance.yahoo.com/news/europe-gl…Europe Glucagon-like Peptide-1 (GLP-1) Agonists ...The Europe GLP-1 agonists market, valued at USD 7.09 billion in 2024, is set to grow at a 17.30% CAGR, reaching USD 14.34 billion by 2034. Driven by rising diabetes and obesity rates, innovative drug formulations, and supportive healthcare policies, the market is expanding. Key players include Eli Lilly, Sanofi, and Novo Nordisk. Challenges involve high costs and regulatory complexities. Opportunities lie in obesity treatment expansion and advanced drug delivery systems. European Glucagon-like P
archivemarketresearch.comarchivemarketresearch.com/reports/peptid…Peptide-Based Drug Delivery System 2025 to Grow at XX ...The peptide-based drug delivery system market is experiencing robust growth, projected to reach $43.88 billion in 2025. While the precise CAGR isn't provided, considering the presence of major pharmaceutical players like Sanofi, Novo Nordisk, and Eli Lilly, and the inherent advantages of peptide drug delivery (improved bioavailability, targeted delivery, reduced side effects), a conservative estimate of a 7-8% CAGR over the forecast period (2025-2033) seems reasonable. This growth is driven by the increasing prevalence of chronic diseases requiring effective therapies, advances in peptide synthesis and conjugation technologies enabling targeted delivery to specific cells or tissues, and ongoing research and development leading to novel peptide-based therapeutics for a wide range of conditions. The market is further propelled by the limitations of traditional drug delivery methods, particularly for peptide and protein drugs, which often suffer from poor stability and rapid degradation in the body. Peptide-based systems overcome these hurdles, leading to increased patient compliance and improved treatment outcomes. The market segmentation (unspecified in the provided data) likely includes various delivery methods (e.g., liposomes, nanoparticles, microspheres), therapeutic applications (e.g., oncology, diabetes, cardiovascular diseases), and routes of administration (e.g., intravenous, subcutaneous, oral). Competition within the market is intense, with numerous established pharmaceutical companies actively involved. However, the significant growth potential is attracting investment in emerging technologies and smaller biotech firms. Challenges remain, such as the high cost of peptide synthesis and the complexities involved in achieving targeted delivery and sustained release. Nevertheless, ongoing innovation in these areas is expected to mitigate these challenges and further fuel market expansion in the coming years, leading to considerable opportunities for players across the value chain.
Towards Healthcaretowardshealthcare.com/insights/oral-…Oral Proteins & Peptides Market to Rise at 16.34% CAGR ...The oral proteins & peptides market size is projected to expand from USD 9.36 billion in 2025 to USD 36.35 billion by 2034, with a CAGR of 16.34%.
MarketsandMarketsmarketsandmarkets.com/PressReleases/…Oral Proteins & Peptides Market worth $19.93 billion by 2030The oral proteins & peptides industry is projected to grow from USD 9.31 billion in 2025 and to reach USD 19.93 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 16.4% during the forecast period.
American Speech-Language-Hearing Associationpmc.ncbi.nlm.nih.gov/articles/PMC11…Regulatory Guidelines for the Analysis of Therapeutic ...Social communication disorder is a deficit in the use of language in social contexts, which can affect language expression and comprehension.
Jundishapur Journal of Natural Pharmaceutical Productsbrieflands.com/articles/jjnpp…Current Status of Peptide Medications and the Position ...Peptides are highly potent, selective, and relatively safe therapeutics. Over the past two decades, natural peptides have been obtained, studied, and eventu...
Euronews.comeuronews.com/business/2024/…Weight loss market: Smaller rivals muscle in on Eli Lilly and ...As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders.
GrandViewIncgrandviewresearch.com/industry-analy…GLP-1 Receptor Agonist Market Size & Share Report, 2030The global GLP-1 receptor agonist market size was estimated at USD 53.46 billion in 2024 and is projected to grow at a CAGR of 17.46% from 2025 to 2030
CNBCcnbc.com/2025/08/24/eli…Eli Lilly's obesity pill will rival Novo Nordisk's oral Wegovy ...Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions and easier manufacturing.
naturenature.com/articles/d4157…The evolution of the obesity drug marketПросмотрено
Global Market Insights Inc.gminsights.com/industry-analy…Peptide Therapeutics Market Size & Share Report, 2032The peptide therapeutics market was evaluated to be around USD 39.3 billion in 2022 and is projected to witness massive growth at a CAGR of around 7.5% from 2023 to 2032 owing to increasing prevalence of cancer.
Future Market Insightsfuturemarketinsights.com/reports/plant-…Plant Peptides MarketPlant Peptides Market
Precedence Researchprecedenceresearch.com/peptide-therap…Peptide Therapeutics Market Size and Forecast 2025 to 2034The peptide therapeutics market size was calculated at USD 49.13 billion in 2024 and is predicted to hit around USD 83.75 billion by 2034 with a notable CAGR of 5.31%.
Techsci Research Pvt Ltdtechsciresearch.com/report/peptide…Peptide Synthesis Market Size, Report 2030FPeptide Synthesis Market was valued at USD 524.26 Million in 2023 and is expected to reach USD 778.45 Million by 2030 with a CAGR of 6.81%.
uk.finance.yahoouk.finance.yahoo.com/news/peptide-t…Peptide Therapeutics Market Outlook 2025-2030Fbinsightpvtltdfortunebusinessinsights.com/industry-repor…Peptide Therapeutics Market Size, Industry Share, Forecast ...Peptide Therapeutics Market report is segmented summarizes top key players overview as Bachem Holding AG, Eli Lilly, and Company, Pfizer Inc., and more
Roots Analysisrootsanalysis.com/reports/peptid…Peptide Drug Discovery MarketThe peptide drug discovery market is expected to grow at CAGR of 10.5% during the forecast period.
Cision PR Newswireprnewswire.com/news-releases/…Oral Proteins & Peptides Market worth US$24.00 billion by .../PRNewswire/ -- The global Oral Proteins & Peptides Market , valued at US$7.35 billion in 2024, is forecasted to grow at a robust CAGR of 22.1%, reaching...
Precedence Researchprecedenceresearch.com/peptide-therap…Peptide Therapeutics CDMO Market Size, Report by 2034The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
Orion Market Researchomrglobal.com/press-release/…Global Peptide Therapeutics Market Size, Comprehensive ...Peptide therapeutics market was valued at $45.5 million in 2024 and is projected to reach $121.6 million by 2035, growing at a CAGR of 9.4% during the forecast period (2025-2035).
PHARMAnetwork sarl.pharmanetwork.com/magazine/stori…The Peptides & Oligonucleotides Market in Europe and ...PHARMAnetwork magazine offers authoritative insight on world pharmaceutical news and analysis on themes: outsourcing, CDMO, strategy, finance, regulatory, innovation, manufacturing, drug delivery, gener...
PrecedenceResearchprecedenceresearch.com/press-release/…Peptide Therapeutics CDMO Market Sees Innovation in ...The peptide therapeutics CDMO market sees rising momentum as biologics gain traction in treating chronic and rare diseases.
BioXconomybioxconomy.com/modalities/dru…Drug delivery trends in oligo, peptide, mRNA and CRISPR ...In June 2019, we conducted a survey of oligonucleotide, peptide, CRISPR and mRNA therapeutics professionals, exploring the current culture within this emerging sector across discovery, R&D and delivery.
ONdrugDeliveryondrugdelivery.com/drug-delivery-…DRUG DELIVERY TRENDS FOR 2025Tom Oakley and Alex Vasiev look back at how the trends anticipated for 2024 played out in reality and look forward to four major trends expected to influence the drug delivery industry in 2025.
European Pharmaceutical Revieweuropeanpharmaceuticalreview.com/article/254459…Key trends and technologies in drug delivery for 2025 and ...This article outlines key trends shaping drug delivery amid a surge of innovation, including advanced delivery systems and sustainability,
sciencedirectsciencedirect.com/science/articl…Focus on therapeutic peptides and their deliveryfinance.yahoofinance.yahoo.com/news/peptide-t…Peptide Therapeutics Market Outlook 2025-2030Sterling Pharma Solutionssterlingpharmasolutions.com/knowledge-hub/…Step-by-step guide to peptide synthesis and manufacturingRead more about the peptide synthesis and manufacturing process, and discover how the right partner supports successful peptide production.
Drug Target Reviewdrugtargetreview.com/news/155825/ai…AI designs peptides for 'undruggable' diseasesDiscover the groundbreaking AI-based platform that designs peptides to target and destroy previously 'undruggable' disease-causing proteins.
ACS Publicationspubs.acs.org/doi/10.1021/ac…AI-Driven Antimicrobial Peptide Discovery: Mining and ...ConspectusThe escalating threat of antimicrobial resistance (AMR) poses a significant global health crisis, potentially surpassing cancer as a leading cause of death by 2050. Traditional antibiotic discovery methods have not kept pace with the rapidly evolving resistance mechanisms of pathogens, highlighting the urgent need for novel therapeutic strategies. In this context, antimicrobial peptides (AMPs) represent a promising class of therapeutics due to their selectivity toward bacteria and slower induction of resistance compared to classical, small molecule antibiotics. However, designing effective AMPs remains challenging because of the vast combinatorial sequence space and the need to balance efficacy with low toxicity. Addressing this issue is of paramount importance for chemists and researchers dedicated to developing next-generation antimicrobial agents.Artificial intelligence (AI) presents a powerful tool to revolutionize AMP discovery. By leveraging AI, we can navigate the immense sequence space more efficiently, identifying peptides with optimal therapeutic properties. This Account explores the emerging application of AI in AMP discovery, focusing on two primary strategies: AMP mining, and AMP generation, as well as the use of discriminative methods as a valuable toolbox.AMP mining involves scanning biological sequences to identify potential AMPs. Discriminative models are then used to predict the activity and toxicity of these peptides. This approach has successfully identified numerous promising candidates, which were subsequently validated experimentally, demonstrating the potential of AI in AMP design and discovery.AMP generation, on the other hand, creates novel peptide sequences by learning from existing data through generative modeling. This class of models optimizes for desired properties, such as increased activity and reduced toxicity, potentially producing synthetic peptides that surpass naturally occurring ones. Despite the risk of generating unrealistic sequences, generative models hold the promise of accelerating the discovery of highly effective and highly novel and diverse AMPs.In this Account, we describe the technical challenges and advancements in these AI-based approaches. We discuss the importance of integrating various data sources and the role of advanced algorithms in refining peptide predictions. Additionally, we highlight the future potential of AI to not only expedite the discovery process but also to uncover peptides with unprecedented properties, paving the way for next-generation antimicrobial therapies.In conclusion, the synergy between AI and AMP discovery opens new frontiers in the fight against AMR. By harnessing the power of AI, we can design novel peptides that are both highly effective and safe, offering hope for a future where AMR is no longer a looming threat. Our paper underscores the transformative potential of AI in drug discovery, advocating for its continued integration into biomedical research.
Solid Phase 2025solidphase.orgSolid Phase 2025onlinelibrary.wileyonlinelibrary.wiley.com/doi/full/10.10…FDA's stamp of approval: Unveiling peptide breakthroughs ...naturenature.com/articles/s4146…Universal peptide synthesis via solid-phase methods fused ...Labiotech UGlabiotech.eu/best-biotech/a…12 AI drug discovery companies you should know aboutTake a look at 12 of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process.
onlinelibrary.wileyonlinelibrary.wiley.com/doi/abs/10.100…Fundamental Aspects of SPPS and Green Chemical ...finance.yahoofinance.yahoo.com/news/peptide-s…Peptide Synthesis Market Trends Analysis Report 2025-2033Visual Capitalistvisualcapitalist.com/sp/the-58b-wei…The $58B Weight Loss Drug Market in One ChartWeight loss drugs have surged in popularity in recent years, transforming the pharmaceutical landscape. Which brands are dominating this space?
report.polypeptidereport.polypeptide.com/hyr/25/busines…Business review - Half-year report 2025morningstarmorningstar.com/sustainable-in…2 Companies Poised to Capitalize on the Rise of GLP-1 ...Move over, Novo Nordisk and Eli Lilly. Why Pfizer and Roche look like top choices for investors.
Больше результатов
Research Nesterresearchnester.com/ru/reports/pep…В 2024 году объем рынка синтеза пептидов превысил ...Объем мирового рынка синтеза пептидов в 2024 году составлял около 690,75 млн долларов США, и, вероятно, среднегодовой темп роста составит более 7,3%, превысив доход в 1,73 млрд долларов США к 2037 году. К 2037 году доля сегмента реагентов и расходных материалов будет составлять 53%, что обусловлено растущей потребностью в пептидах при открытии и исследованиях лекарств, что приведет к увеличению спроса на реагенты и расходные материалы.
Data Bridge Market Research, https://www.databridgemarketresearch.com, All right reserved 2025databridgemarketresearch.com/ru/reports/glo…Глобальный рынок пептидной терапии – тенденции ...Рынок пептидных препаратов составил 44 699,15 миллионов долларов в 2023 году, подскочит до 68 553,89 миллиона долларов и ожидается, что вырастет с темпом 6,3% к 2030 году.
Kings Researchkingsresearch.com/ru/peptide-syn…Рынок пептид -синтеза, отчет о доле и росте, 2032Предполагается, что рынок пептидного синтеза достигнет 1601,2 млн. Долл. США к 2032 году с 812,3 млн. Долл. США в 2025 году, в течение 10,10% в течение 10,10% в 2025-2032 годах.
Global Market Insights Inc.gminsights.com/ru/industry-an…Объем рынка наноматериалов на основе пептидовОбъем рынка наноматериалов на основе пептидов превысил 4,5 млрд долларов США в 2024 году и, по оценкам, в период с 2025 по 2034 год будет зафиксирован среднегодовой темп роста в 9,5% в связи с растущим спросом на целевые системы доставки лекарств в терапевтических целях.
Emergen Researchemergenresearch.com/ru/industry-re…Peptide Synthesis Market Прогноз - ПептидPeptide Synthesis Market Ознакомьтесь с последними данными. Включает новые тренды, анализ сегментов и прогнозы долей рынка до 2034 года.
Mordor Intelligencemordorintelligence.com/ru/industry-re…Объем рынка синтеза косметических пептидовПрогнозируется, что на мировом рынке синтеза косметических пептидов среднегодовой темп роста составит 5,5% в течение прогнозируемого периода (2024-2029 гг.).
Future Market Insightsfuturemarketinsights.com/ru/reports/all…Размер и прогноз рынка иммунотерапии аллергии на ...Изучите инновации в области иммунотерапии аллергии: от сублингвальных препаратов до персонализированных десенсибилизирующих терапий, стимулирующих рост рынка.
verifiedmarketreportsverifiedmarketreports.com/ru/product/ant…Размер рынка антимикробных пептидов, расширение ...КиберЛенинкаcyberleninka.ru/article/n/osno…ОСНОВНЫЕ КОНЦЕПЦИИ СИНТЕЗА ПЕПТИДОВ КАК ...